基于结构的发现,一个非竞争性的FTO抑制剂被绑定到域界面的加密站点
Aayushi Singh1, Francesco Pettini2, Beatrice Gianibbi3
1Department of Chemistry, Iowa State University, Ames, IA, USA.
Journal of molecular biology
|December 7, 2025
概括
研究人员发现了一种新的分子支架,可以选择性地抑制脂肪质量和与肥胖相关的 (FTO) 蛋白质. 这种全抑制剂向一个神秘的部位,为治疗代谢疾病和癌症提供了一种新的策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 脂肪质量和与肥胖相关的 (FTO) 蛋白质与肥胖,2型糖尿病,阿尔茨海默病和癌症有关.
- 目前的FTO抑制剂具有竞争力,在实现子家族选择性方面面临挑战.
- 开发选择性FTO抑制剂对于制药研究至关重要.
研究的目的:
- 发现一种用于选择性FTO抑制的新型分子支架.
- 描述新脚手架的绑定模式和抑制机制.
- 探索FTO相关疾病的新治疗策略.
主要方法:
- 高通量虚拟选FTO加密口袋.
- 解决方案核磁共振 (NMR) 光谱学. 解决方案核磁共振 (NMR) 光谱学.
- 分子动力学模拟和酶动力学测试.
主要成果:
- 确定了一种分子支架,该支架与FTO结构域之间的神秘位置结合.
- 通过扰乱基质结合来证明非竞争性抑制.
- 在AlkB家族成员中确认了FTO独特的多域结构.
结论:
- 发现的分子代表了FTO.的新型全抑制剂支架.
- 这种方法为开发高度选择性的FTO抑制剂提供了一个有希望的途径.
- 进一步开发可能会导致改善代谢疾病和癌症的治疗策略.
相关概念视频
Conserved Binding Sites
5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
Conserved Binding Sites
1.9K
1.9K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Protein-Protein Interfaces
4.4K
4.4K
Ligand Binding and Linkage
5.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
Allosteric Proteins-ATCase
6.4K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K


